Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 23, 2024

BUY
$90.19 - $110.4 $1.55 Million - $1.9 Million
17,185 New
17,185 $1.89 Million
Q1 2023

Apr 25, 2023

SELL
$96.86 - $114.01 $27,798 - $32,720
-287 Reduced 10.29%
2,501 $253,000
Q4 2022

Jan 25, 2023

BUY
$95.06 - $111.52 $11,122 - $13,047
117 Added 4.38%
2,788 $0
Q3 2022

Oct 24, 2022

BUY
$96.76 - $112.03 $24,093 - $27,895
249 Added 10.28%
2,671 $259,000
Q2 2022

Aug 05, 2022

BUY
$102.07 - $123.37 $5,103 - $6,168
50 Added 2.11%
2,422 $264,000
Q1 2022

May 13, 2022

SELL
$114.02 - $139.04 $106,608 - $130,002
-935 Reduced 28.27%
2,372 $281,000
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $7,856 - $9,619
68 Added 2.1%
3,307 $465,000
Q3 2021

Oct 29, 2021

BUY
$116.66 - $129.06 $2,916 - $3,226
25 Added 0.78%
3,239 $383,000
Q2 2021

Jul 29, 2021

BUY
$105.79 - $124.53 $2,221 - $2,615
21 Added 0.66%
3,214 $373,000
Q1 2021

May 06, 2021

BUY
$108.84 - $128.23 $11,210 - $13,207
103 Added 3.33%
3,193 $383,000
Q4 2020

Feb 04, 2021

SELL
$105.0 - $114.42 $525 - $572
-5 Reduced 0.16%
3,090 $338,000
Q3 2020

Nov 10, 2020

BUY
$91.64 - $111.29 $12,554 - $15,246
137 Added 4.63%
3,095 $337,000
Q2 2020

Aug 10, 2020

BUY
$76.57 - $98.0 $4,900 - $6,272
64 Added 2.21%
2,958 $270,000
Q1 2020

May 01, 2020

BUY
$62.82 - $91.86 $31,158 - $45,562
496 Added 20.68%
2,894 $228,000
Q4 2019

Feb 12, 2020

SELL
$78.51 - $87.4 $15,544 - $17,305
-198 Reduced 7.63%
2,398 $208,000
Q3 2019

Nov 12, 2019

SELL
$81.84 - $88.74 $3,355 - $3,638
-41 Reduced 1.55%
2,596 $217,000
Q2 2019

Jul 26, 2019

SELL
$72.88 - $85.0 $5,830 - $6,800
-80 Reduced 2.94%
2,637 $222,000
Q1 2019

May 13, 2019

BUY
$66.22 - $80.06 $179,919 - $217,523
2,717 New
2,717 $217,000
Q4 2018

Feb 11, 2019

SELL
$65.56 - $74.27 $181,207 - $205,282
-2,764 Closed
0 $0
Q3 2018

Oct 31, 2018

BUY
$60.81 - $73.36 $168,078 - $202,767
2,764 New
2,764 $203,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Halbert Hargrove Global Advisors, LLC Portfolio

Follow Halbert Hargrove Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Halbert Hargrove Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Halbert Hargrove Global Advisors, LLC with notifications on news.